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RESEARCH ARTICLE
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Abstract
Disease-associated loci identified through genome-wide association studies (GWAS) fre-
quently localize to non-coding sequence. We and others have demonstrated strong enrich-
ment of such single nucleotide polymorphisms (SNPs) for expression quantitative trait loci
(eQTLs), supporting an important role for regulatory genetic variation in complex disease
pathogenesis. Herein we describe our initial efforts to develop a predictive model of dis-
ease-associated variants leveraging eQTL information. We first catalogued cis-acting
eQTLs (SNPs within 100kb of target gene transcripts) by meta-analyzing four studies of
three blood-derived tissues (n = 586). At a false discovery rate < 5%, we mapped eQTLs for
6,535 genes; these were enriched for disease-associated genes (P < 10−04), particularly
those related to immune diseases and metabolic traits. Based on eQTL information and
other variant annotations (distance from target gene transcript, minor allele frequency, and
chromatin state), we created multivariate logistic regression models to predict SNP
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membership in reported GWAS. The complete model revealed independent contributions
of specific annotations as strong predictors, including evidence for an eQTL (odds ratio
(OR) = 1.2–2.0, P < 10−11) and the chromatin states of active promoters, different classes of
strong or weak enhancers, or transcriptionally active regions (OR = 1.5–2.3, P < 10−11).
This complete prediction model including eQTL association information ultimately allowed
for better discrimination of SNPs with higher probabilities of GWASmembership (6.3–
10.0%, compared to 3.5% for a random SNP) than the other two models excluding eQTL
information. This eQTL-based prediction model of disease relevance can help systemati-
cally prioritize non-coding GWAS SNPs for further functional characterization.
Introduction
The vast majority (88%) of complex disease-associated single nucleotide polymorphisms
(SNPs) identified by genome-wide association studies (GWAS) are non-coding variants [1].
Genomic analyses of these SNPs, or their proxies in strong linkage disequilibrium (LD), find
significant enrichment for putative functional regulatory regions that can affect the expression
of nearby genes [2–4], further supporting an important role for regulatory genetic variation in
disease pathogenesis and motivating extensive cataloging of such variation [5]. In contrast to
disease-associated variants localized to the coding regions of gene transcripts, distinguishing
functionally relevant non-coding variants from their more numerous irrelevant counterparts is
considerably more challenging [6].
In particular, expression quantitative trait locus (eQTL) mapping, a genetic method that
relates SNP allelic variation to target transcript abundance [7], could provide valuable informa-
tion for prioritizing disease GWAS results. Performed in diverse tissues and cell types, eQTL
studies have identified thousands of regulatory variants that, on average, individually explain
~10% of population variability in gene expression at each locus [8], and are collectively signifi-
cantly enriched for disease-associated variants [2, 3, 8–10]. Given that there are multiple lines
of genomic evidence for the functionality of eQTLs [11], we propose that improved prioritiza-
tion of non-coding genetic variation reported in disease-association mapping studies can be
achieved by combining SNP-specific eQTL information together with other relevant annota-
tions, such as putative regulatory chromatin states [12], to develop multivariate prediction
models. Herein we describe such an approach.
An important first step in the development of a high-performing model is ensuring the
accuracy of the variables (i.e., sequence features) being considered as model predictors. In the
case of eQTL data, a major concern relates to the statistical power to detect such associations.
Though the effects of SNPs on gene expression variability are typically much stronger than
their downstream effects on trait liability [7], like all genetic studies, eQTL analyses are often
limited in their statistical power; heritability estimates in twin studies suggest that a substantial
proportion of the total genetic variability of gene expression remains unexplained [8, 9].
Indeed, the yield of individual eQTL studies is strongly correlated with study sample size, with
the greatest number of variants identified in the few studies that include thousands of subjects
[9, 13]. Given the increasing availability of results from eQTL studies, meta-analysis of smaller
existing datasets is a natural solution for increasing power to identify additional regulatory var-
iants. Descriptions of the many technical considerations of eQTL meta-analytic approaches
have been reported [14–18], including current hurdles for novel eQTL discovery using already
published datasets [19]. In this study, we meta-analyzed data on 586 subjects from four cohorts
to identify cis-eQTLs among three blood-derived tissues.
eQTL Information Aids Predictive Genetic Model of Disease Relevance
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Information on the strength of association for these blood-derived eQTLs was then used in
conjunction with other genomic SNP annotations to develop predictive models of disease rele-
vance. While all the resulting models improved our ability to distinguish disease-associated
variants from others, the model that included eQTL association information out performed
those that did not, demonstrating the utility of eQTL information in prioritizing for further
study non-coding genetic variation associated with complex diseases.
Materials and Methods
Expression and genotype data
Expression and genotype data from four cohorts of unrelated individuals of non-Hispanic
European ancestry were studied: peripheral blood CD4+ lymphocytes (CD4) sampled from 80
individuals with asthma participating in the Childhood Asthma Research and Education Net-
work (CARE) [20]; lymphoblastoid cell lines (LCL) from 115 individuals in the Centre d'Etude
du Polymorphisme Humain (CEPH) International HapMap Project population (CEU) [21];
and CD4+ cells (n = 200) and whole blood (WB) samples (n = 216) from two subsets of asth-
matics participating in the Childhood Asthma Management Program (CAMP) [22]. The
CARE CD4 and CAMPWB expression data were generated using Illumina HT12 arrays (v3
and v4, respectively; Illumina, Inc., San Diego, CA), as part of the Asthma BioRepository for
Integrative Genomic Exploration (W. Qiu et al., 2012, American Thoracic Society, abstract).
The CAMP CD4 and CEU LCL expression data were generated using Illumina Human-Ref8
v3 BeadChip arrays [3, 23]. We identified 12,889 expression probes that were (1) represented
on both platforms and testable in all four populations, (2) located on autosomes, (3) mapped
uniquely to the genome, (4) not affected by any known SNP-under-probe effect, and (5) con-
sidered either “Good” or “Perfect” using the Illumina annotation algorithm described by Bar-
bosa-Morais et al. [24]. Approval was obtained from the Institutional Review Boards (IRB) of
Brigham and Women's Hospital (Boston, MA) and each of the participating institutions for
CAMP and CARE. Written informed consent was obtained from those study participants.
Detailed methods of genome-wide SNP genotyping have been described elsewhere for CEU
[25], CARE [26], and CAMP [3, 27]. A common set of SNP genotypes was obtained by imputa-
tion in each cohort using MaCH (version 1.0) [28] and the 1000 Genomes Project EUR refer-
ence phased haplotypes based on Phase 1 low coverage data (20101123 release). For fifty-two
CEU individuals directly sequenced as part of the 1000 Genomes Project, we substituted actual
genotype data in place of imputed data. SNPs with minor allele frequency (MAF)< 1%, a
Hardy-Weinberg equilibrium P< 0.001, and/or an imputation quality score< 0.3, were
excluded, resulting in a set of ~37 million variants per cohort. We performed principal compo-
nent analysis (PCA) of the genotypes in each cohort using EIGENSOFT (version 3.0) [29, 30].
Genetic outliers identified based on Tracy-Widom statistics computed on the genotype PCs by
the accompanying utility TWSTATS [30] were removed from further analysis. The total num-
bers of remaining individuals were thus n = 73 for CARE CD4, n = 113 for CEU LCL, n = 198
for CAMP CD4, and n = 202 for CAMPWB.
Association testing
The gene expression data were first quantile-normalized across the four cohorts and adjusted
for age, gender, and known batch variables. To account for unmeasured confounders, within
each population, we empirically determined the number of gene expression principal compo-
nents (PCs) to adjust for in order to maximize the number of nominally significant eQTL asso-
ciations identified (P< 0.05). SNPs were iteratively tested for associations with age- and
gender-adjusted expression residuals with increasing numbers of gene expression PCs. The
eQTL Information Aids Predictive Genetic Model of Disease Relevance
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expression PCs corresponding to the 21, 19, 31, and 32 largest eigenvalues in CARE CD4, CEU
LCL, CAMP CD4, CAMPWB, respectively, were thus adjusted for using the “clipPCs” func-
tion from the R package “GGBase” (version 3.24) from Bioconductor (release 2.14) [31], which
provides base programmatic infrastructure for the study of the genetics of gene expression. The
expression and genotype datasets for each cohort were then bundled together into “smlSet”
data objects to conveniently facilitate downstream analyses in a unified Bioconductor workflow
within R (version 3.1). Access to the source genotype and expression datasets for the CAMP
and CARE cohorts must be approved by the corresponding study IRBs.
To systematically assess the genotype-expression association landscape in cis for each gene
(probe), all SNPs within a search radius of 100 kb from a given pair of target transcript flanks
were tested for evidence of being an eQTL. This search was facilitated by the "All.cis" function
from the R package “GGtools” (version 4.10) [32] from Bioconductor, which provides analyti-
cal tools for the study of the genetics of gene expression. The gene boundaries were based on
the “knownGene” track downloaded from the University of California Santa Cruz (UCSC)
Genome Browser [33]. Each cohort-specific SNP-probe association was represented by a one
degree-of-freedom χ2 test statistic.
We then performed a meta-analysis of the cis-eQTL associations from all four populations by
summing together their corresponding test statistics into a single four degrees-of-freedom χ2 test
statistic. In all association analyses, a false discovery rate (FDR) for each eQTL association was
estimated by permutation testing (k = 3 permutations) using an implementation of a plug-in FDR
methodology (Algorithm 18.3) [34]. Briefly, the plug-in FDR algorithm obtains hundreds of mil-
lions of realizations of the null distribution of the association statistic through multiple genome-
wide permutations of genotype against expression for all SNP-gene pairs in cis. Tail probabilities
for extreme values of the observed statistic are estimated accurately and realistically from this
ensemble of realizations of the null distribution and provide our estimates of the FDRs. Gene-wise
FDRs optimized over all SNPs cis to each gene were thus calculated using the "collectFiltered"
function from GGtools. The overlaps among the meta-analysis cohorts of the sets of genes with
significant eQTLs were visualized using functions from the R package “VennDiagram” (version
1.6). To evaluate the replicability of the meta-analysis results, a list of previously published eQTL
genes was downloaded from the supplementary materials of a study inWB byWestra et al. [13].
GWAS enrichment and prediction analyses
To assess the relationship of the observed meta-analysis eQTL genes with known GWAS genes,
we calculated the proportion of GWAS genes harboring a least one significant meta-analysis
eQTL SNP (FDR< 5%). As input, we obtained a set of 12,161 gene identifiers reported in 9,764
entries in the National Human Genome Research Institute (NHGRI) GWAS Catalog (accessed
28 November 2012, https://www.genome.gov/gwastudies/) [1], Identifiers listed in the NGHRI
GWAS Catalog as “genes” but not matching any gene names found in the UCSC Genome
Browser were removed, including instances of “intergenic” (n = 1,091), “NR” for “Not Reported”
(n = 685), “pseudogene” or other terms that indicated a non-genic locus, and non-standard gene
identifiers, resulting in a final set of 4,250 unique GWAS genes. Enrichment and its significance
was determined by comparing the observed proportion of eQTL genes among a given test gene
set to a null distribution of 10,000 draws of the same number of random genes from across the
genome (represented by a set of 19,058 UCSC Genome Browser genes). We performed enrich-
ment analyses of manually curated candidate subsets of genes associated with inflammatory dis-
eases and traits, metabolic traits, mental health traits, cancers, and adult height.
To predict whether a given SNP (and its target probe) was in the set of GWAS index SNPs
or their close proxies from the NHGRI GWAS Catalog, we developed a set of three multivariate
eQTL Information Aids Predictive Genetic Model of Disease Relevance
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generalized logistic regression models in R incorporating different combinations of SNP anno-
tation information in the forms of factored variables related to the genomic distance of a given
SNP from the transcript boundaries of its target gene, its MAF bin, its eQTL FDR bin, and its
predicted regulatory chromatin state in GM12878 LCLs based on genomic data from the Ency-
clopedia of DNA Elements (ENCODE) [12]. To develop a training set of eQTLs for the model,
a set of 381,491 independent SNPs from across the genome was identified in the EUR panel of
the 1000 Genomes Project (Phase 1, version 3) using the default settings for variance inflation
factor-based pruning implemented in PLINK (version 1.07) [35]. These SNPs were located in
cis to 11,864 unique probes, resulting in 777,998 SNP-probe pairs in the training set. To com-
pare their relative contributions, the effect betas from the training set of each predictive model
were plotted using the “forestplot” function from the R package “rmeta” (version 2.16), which
provides tools for visualizing meta-analysis results. Corresponding receiver operating charac-
teristic (ROC) curves for the predictive models were generated using the “roc” function from
the R package “pROC” (version 1.8) [36], which provides tools for visualizing and analyzing
ROC curves. For an additional comparison, scores from version 1.0 of the Combined Annota-
tion Dependent Depletion (CADD) [37] resource were also included as a model predictor. The
scaled CADD scores were turned into factored variables based on the following bins: [0, 5],
(5,10], (10, 20], (20,30], (30, 60].
Results
The goal of this study was to develop a multivariate prediction model to prioritize the further
study of non-coding genetic variation with greatest relevance to disease pathogenesis. We
based this model on several relevant SNP annotation predictors, including distance from target
gene transcript, minor allele frequency, chromatin states, and association evidence for being a
cis-eQTL. To optimize the quality of our eQTL information, we first conducted a meta-analysis
of eQTL associations from four cohorts representing three blood-derived tissues (n = 586 sub-
jects). We first describe the results of this meta-analysis, followed by the results of our predic-
tion model building.
eQTL meta-analysis yields and performance
Compared to the eQTL analysis of each cohort individually, the meta-analysis considering all
586 individuals resulted in substantial gains in the number of regulatory variants identified
(Table 1). In contrast to the individual cohort analyses, where we identified between 626 and
5,363 unique genes with significantly associated eQTLs (corresponding to between 21,415 and
366,077 significantly associated pairs of SNPs and their respective target gene expression
probes at an FDR< 5%, P = 2.6 × 10−07 to 3.6 × 10−04), the meta-analysis identified a total of
6,535 eQTL genes (488,290 SNP-probe pairs, P = 1.9 × 10−81 to 3.5 × 10−03). A quantile-quan-
tile plot of the meta-analysis associations showed a very substantial enrichment in the right-
hand tail of the observed distribution above the permuted null distribution (S1 Fig). The full
meta-analysis and cohort-specific eQTL results have been made available on-line (https://
regepi.bwh.harvard.edu/projects/eQTLMeta/).
Total numbers of SNPs only include those located within 100 kb of target gene trancripts.
Multiple probes may target the same gene. In each of the four study cohorts (“CARE CD4”,
“CEU LCL”, “CAMPWB”, and “CAMP CD4”) and in their combined meta-analysis (“META”),
eQTL association significance was defined as an FDR< 5% (seeMaterials and Methods). The
corresponding minimum and maximum uncorrected P values are also reported.
The individual cohorts together implicated 7,222 unique eQTL genes and an additional 788
were identified only through the subsequent meta-analysis (Figs 1 and 2). Among these total
eQTL Information Aids Predictive Genetic Model of Disease Relevance
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Table 1. Summary characteristics of cohort-specific andmeta-analysis eQTL results.
CARE CD4 CEU LCL CAMP CD4 CAMP WB META
Sample Size 73 113 198 202 586
Total # SNPs 4,253,296 4,119,125 4,243,510 4,260,335 3,804,162
# Signif. SNPs 20,577 60,217 319,846 229,849 421,377
Total # Genes 11,121 10,924 11,121 11,121 10,924
# Signif. Genes 626 2,184 5,363 4,155 6,535
Total # SNP-Probe Pairs 9,153,510 8,305,457 9,138,022 9,168,425 7,672,940
# Signif. SNP-Probe Pairs 21,415 64,491 366,077 254,186 488,290
Min. Signif. Nominal P Value 1.84E-12 1.22E-21 2.62E-31 2.58E-37 1.95E-81
Max. Signif. Nominal P Value 4.43E-04 1.44E-03 3.57E-04 2.26E-03 3.53E-03
doi:10.1371/journal.pone.0140758.t001
Fig 1. Venn diagram of overlaps of eQTL genes identified in specific individual cohorts and throughmeta-analysis.Numbers represent counts of
genes with at least one significant eQTL SNP (FDR < 5%) in each of the four study cohorts (“CAMPWB”, “CAMPCD4”, “CEU LCL”, and “CARE CD4” in
white ellipses) and in their combined meta-analysis (“META” in gray ellipse). Total counts for each group are also summarized in Table 1.
doi:10.1371/journal.pone.0140758.g001
eQTL Information Aids Predictive Genetic Model of Disease Relevance
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Fig 2. Relationships of eQTLmeta-analysis gene yields with representation in individual cohorts and
a previous study.Counts of all significant eQTL genes (meta-analysis FDR < 5%, Table 1) identified per
source category are shown with white bars. The first four categories (“1C” through “4C”) represent the
number of individual cohorts in which a gene was identified. The fifth category (“UNION”) is the union of the
genes from the preceding four categories. The sixth category (“META”) is the set of genes identified in the
meta-analysis. Top panel: For comparison, the counts of genes in each category also found by the meta-
analysis are shown with overlapping gray bars. Among genes found in the meta-analysis, the count of genes
not identified in any of the individual cohorts is shown with a black bar. Bottom panel: The counts of genes
found in an eQTL study in WB byWestra et al. [13] are shown with black bars.
doi:10.1371/journal.pone.0140758.g002
eQTL Information Aids Predictive Genetic Model of Disease Relevance
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8,010 eQTL genes identified, the strongest evidence existed for the 257 genes that were detected
in each of the four cohorts and also by the by meta-analysis (Fig 1). Of the remainder, 3,156
genes were detected in two or three cohorts and in the meta-analysis; 2,334 were unique to one
cohort and also detected in the meta-analysis (Fig 2). A total of 1,475 genes were only detected
in individual cohorts but were not significant in the meta-analysis. Of these, 1,251 (85%) were
observed in only one of the four cohorts, suggesting they may represent either false positive
results or tissue-specific eQTL signals drowned out by the meta-analysis.
We then evaluated the replicability of the 6,535 eQTL genes detected in our meta-analysis
by examining their overlap with 6,368 genes reported in a substantially larger eQTL study
(n = 5,311 samples) of whole blood by Westra et al. [13]. Overall, 3,040 (46%) of 6,535 genes
detected in our meta-analysis were also reported by Westra et al. (Fig 2). The degree of overlap
between the two studies was greatest for those eQTL genes with greatest evidence of association
in the meta-analysis and conversely declined with the strength of association. Genes with an
FDR< 5% in the meta-analysis and in all four individual cohorts showed 65% overlap with
Westra et al. Genes detected by meta-analysis and in only one cohort showed 49% overlap.
Finally, overlap was lowest (20%) for those genes detected in only one cohort but not detected
by meta-analysis. Notably, overlap was greater for eQTL genes detected by meta-analysis alone
(26%) compared to those detected only in one cohort (20%), suggesting that even the weakest
category of meta-analysis results were more often replicated than the results from only single
cohorts.
The relationship of eQTLs to disease-associated loci
Given the reported enrichments of disease-associated variants for eQTLs [2, 3, 9] and for other
functional sequence annotations [11, 12], we next assessed the relationship of the eQTL genes
detected in the meta-analysis with disease-associated genes by comparing their representation
in the NHGRI GWAS Catalog. Among the 6,535 eQTL genes detected by meta-analysis,
950 (14.5%) were previously reported as GWAS loci, representing a significant enrichment
among GWAS genes those that harbor at least one eQTL (P< 10−04) (Fig 3). This enrichment
appeared to be most robust for genes associated with inflammatory, metabolic and mental
health traits. Though we have previously reported associations with height- and cancer-associ-
ated regulatory variants detected in CD4+ lymphocytes [3], there were no significant enrich-
ment for meta-analysis eQTLs for these disease categories (P 0.05), possibly reflecting the
larger proportion of samples from peripheral blood contributing to the meta-analysis.
eQTL information for improved disease SNP prediction
We next developed multivariate logistic predictive models of the likelihood of a SNP being a
“GWAS hit”, namely being reported in the GWAS Catalog (or having a close proxy at r2>
0.8). The complete model (“chromstate+eqtl [M3]”) considered multiple SNP features, includ-
ing physical distance from target transcript, MAF, putative chromatin state in LCLs [12], and
strength of eQTL association as estimated from our meta-analysis (Fig 4). For comparison, we
also examined two smaller models: one that considered physical distance from target tran-
script, MAF, and the variants’ position relative to transcript (“structure [M1]”) and one that
considered physical distance from target transcript, MAF, and the chromatin state annotations
(“chromstate [M2]”) (S2 Fig). MAF was included in all models to adjust for the overrepresenta-
tion of common variants in the GWAS Catalog, which is a reflection of the inherent power-
related bias of GWAS to detect associations with common variants.
We trained these three predictive models on the same random subset of 777,998 SNP-probe
pairs, and then validated the predictive power of each model by testing against the remaining
eQTL Information Aids Predictive Genetic Model of Disease Relevance
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6,894,942 SNP-probe pairs that were not included in the training set. While a randomly
selected SNP-probe pair in the test set had a 3.5% chance of being a GWAS hit, all three models
predicted substantial subsets of pairs to have even higher probabilities (Fig 5). All three models
were well-calibrated in that for SNP-probe pairs found in a given bin of predicted probabilities,
the actual observed proportion of GWAS hits among those pairs was within that predicted
range. However, our complete model M3 that considered both eQTL evidence and chromatin
state outperformed the smaller models M1 and M2 in one important regard: whereas the
Fig 3. Genes associated with inflammatory and other categories of disease traits enriched for meta-analysis eQTL genes. In each histogram, the
observed number of genes in the given category harboring at least one significant eQTL SNP (meta-analysis FDR < 5%) is marked with a dashed vertical
line. The null distributions derived from 10,000 permutations are shown with gray bars.
doi:10.1371/journal.pone.0140758.g003
eQTL Information Aids Predictive Genetic Model of Disease Relevance
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maximum predicted probabilities generated by M1 and M2 peaked at 6.0% and 5.3%, respec-
tively (corresponding to maximum 1.7-fold and 1.5-fold chances, respectively, of being a
GWAS hit compared to random), M3 derived probabilities had a greater dynamic range and
was able to provide higher prediction probabilities as high as 10.0% (2.9-fold higher than
chance). ROC curves for the three models showed that they were all reasonable classifiers (Fig
6), with the area under the ROC curve (AUC) being 0.645 for M1, 0.610 for M2, and 0.654 for
M3. Thus, while all three of our models were improvements over chance, the model consider-
ing eQTL information was most discriminatory and most strongly predicted SNPs that would
be prioritized for further functional characterization.
Fig 4. Forest plot of component effects of complete GWAS predictive model based on training set of SNPs.Odds ratios (black squares) from the
complete multivariate model (“chromstate+eqtl [M3]”) for features predicting the membership of a SNP in the NHGRI GWASCatalog are shown here with
standard errors (gray lines). Smaller models are shown for comparison in S2 Fig. Four classes of SNP annotation are represented in the model, each with
multiple levels: distance from gene, MAF, chromatin state in GM12878 LCLs (12), and evidence of eQTL association based on meta-analysis FDR. The base
levels for each annotation are “0 kb (within gene)” [Distance fromGene], “>10%” [MAF], “Heterochromatin (13)” [ChromHMM], and “>50%” [FDR].
doi:10.1371/journal.pone.0140758.g004
eQTL Information Aids Predictive Genetic Model of Disease Relevance
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The observation that the complete prediction model (M3) including eQTL information out-
performed the two that did not suggested that despite the fact that eQTLs frequently overlap
annotated chromatin structures the eQTLs provided additional complementary and indepen-
dent predictive information regarding the disease relevance of a given SNP. This is confirmed
upon inspection of Fig 4, which presents the multivariate adjusted odds ratios (OR) for each
feature considered in the M3 model. Strong evidence of association was observed for both
eQTL potential (OR = 1.2–2.0 for SNPs with FDR between 0 and< 50%, P = 1.2 × 10−12 to
7.9 × 10−91) and for many of the chromatin states, including those that commonly harbor
Fig 5. Multivariate logistic models predicting SNPmembership in GWAS are well-calibrated. Top panel: Three models were developed for predicting
the membership of a given SNP in the NHGRI GWAS Catalog, all incorporating at minimum the distance of the SNP from the transcript boundaries of its
target gene and the minor allele frequency of the SNP. The "structure [M1]" model (white) also incorporates the NCBI gene structure classification of the gene
(intron, coding, untranslated region, etc.) (S2 Fig); "chromstate [M2]" (gray) instead incorporates chromatin state (S2 Fig); "chromstate+eqtl [M3]" (black)
incorporates both chromatin state and eQTL FDR class (Fig 4). The x-axis shows equal-sized bins of predicted probabilities of being a GWAS SNP. This
particular choice of bins based on the widest range of probabilities (fromM3) aids visual comparison of calibration among the three models by smoothing the
proportions of observed GWAS SNPs. The y-axis shows the actual proportion of GWAS SNPs in that bin. The dashed green line at 3.5% represents the
mean probability of a random SNP in the genome for being a GWAS hit or a close proxy (r2 > 0.8) for one. Bottom panel: a table of absolute counts of SNPs in
each predicted probability bin for each of the predictive models. For the M1 and M2 models, no SNPs had predicted probabilities > 6.3%.
doi:10.1371/journal.pone.0140758.g005
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eQTLs, such as active promoters (#1), a class of strong enhancers (#4), a class of weak enhanc-
ers (#7), regions of transcription elongation (#9), and regions of transcription transition (#10)
(OR = 1.5–2.3, P = 7.1 × 10−12 to 1.7 × 10−145). Moreover, all of the 78,228 SNP-probe pairs in
the two highest bins of probability (with a minimum predicted probability of 6.3% of being a
GWAS hit) had both strong evidence for eQTL association and resided in one of these specific
functional elements (Table 2). The corresponding 3,291 gene regions originally included
2,067,404 SNP-probe pairs, meaning that for those regions the predictive model reduced by
96.2% the set of eQTLs to inspect further. Of the 78,228 eQTLs, 7,101 (9.1%) were annotated as
known GWAS hits, representing 5,644 distinct SNPs and 546 distinct genes. These results sug-
gested that the gain in predictive power in the complete model was a function of the eQTL
information to differentiate among SNPs with multiple relevant functional annotations. Fur-
thermore, when we included published scores of predicted SNP pathogenicity from CADD
[37] as an additional parameter to M3, there was no substantive change in overall predictive
Fig 6. ROC curves for multivariate logistic models predicting SNPmembership in GWAS.Components of the three predictive models are described in
Fig 5.
doi:10.1371/journal.pone.0140758.g006
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power (M3+CADD, AUC = 0.652) or in the effect estimates of the original predictors (data not
shown), reinforcing the notion that our model robustly captured similar information about the
disease relevance of non-coding SNPs.
A total of 78,228 SNP-probe pairs (representing 64,495 distinct SNPs and 3,291 distinct
genes) were located in the two highest GWAS prediction bins (6.3–10.0%) from the complete
prediction model (M3) applied to the testing set. Chromatin states were defined in GM12878
LCLs [12]. CNV, copy number variant; Txn, transcription/transcriptional.
Examining the relative magnitude of the predictive strength of each feature in the complete
model provided several important insights regarding the prioritization of candidate SNPs (Fig
4). First, as anticipated, MAF was a significant predictor of GWAS Catalog membership, with
the probability of being a GWAS hit being inversely proportional to MAF (OR = 0.17–0.47 for
SNPs with MAF 10%, P = 0 to 2.0 × 10−275). This was most likely a consequence of the inher-
ent property of GWAS being powered to detect common variants; a biological explanation,
however, cannot be dismissed outright.
Second, though chromatin state was an important predictor of GWAS association, we
observed substantial heterogeneity within this category of classifiers, including substantial dif-
ferences between seemingly related states. For example, active promoters were among the
strongest predictors (OR = 1.9, P = 1.7 × 10−34), whereas weak promoters show much weaker
association (OR = 1.2, P = 5.1 × 10−02) and poised promoters provided no discriminatory infor-
mation (OR = 0.99, P = 0.94). Similarly though there were two types of “strong” (#4 and #5)
and “weak” (#6 and #7) enhancers, their strengths of association were highly variable
(OR = 1.5, P = 7.6 × 10−12 versus OR = 1.2, P = 5.2 × 10−02; and OR = 1.3, P = 2.1 × 10−04 versus
OR = 1.6, P = 1.0 × 10−28, respectively). This observation of the importance of specific chroma-
tin states was further illustrated by the sparseness of Table 2, where notably only two of the
four enhancer types (strong #4 and weak #7) were represented in the highest prediction bins.
Thus, although similar in annotation, there appeared to be important differences in the disease
potentials between related chromatin states.
Table 2. Functional annotations of SNP-pairs most strongly predicted to be in GWAS loci.
Meta-analysis FDR bin
Chromatin state [0–1%) [1–5%) [5–10%) [10–50%) [50–100%]
(-) none 0 0 0 0 0
(1) Active Promoter 7,812 244 960 0 0
(2) Weak Promoter 0 0 0 0 0
(3) Poised Promoter 0 0 0 0 0
(4) Strong Enhancer 2,537 0 0 0 0
(5) Strong Enhancer 0 0 0 0 0
(6) Weak Enhancer 0 0 0 0 0
(7) Weak Enhancer 6,703 0 0 0 0
(8) Insulator 0 0 0 0 0
(9) Txn Transition 5,704 1,705 1,317 0 0
(10) Txn Elongation 46,940 144 4,162 0 0
(11) Weak Txn 0 0 0 0 0
(12) Repressed 0 0 0 0 0
(13) Heterochromatin 0 0 0 0 0
(14) Repetitive/CNV 0 0 0 0 0
(15) Repetitive/CNV 0 0 0 0 0
doi:10.1371/journal.pone.0140758.t002
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Third, our model provided greater insight into the relative importance of distance from
transcript as a predictor of variant function. Though it is well known that eQTL-associated
SNPs are most abundant in close proximity to their target gene [3], the relative impact of dis-
tance from transcript as a predictor was relatively modest after multivariate adjustment for
eQTL and chromatin state annotations (OR = 1.1–1.2, P = 2.5 × 10−02 to 5.9 × 10−11). To better
appreciate the importance of distance as an independent predictor, we ran an additional analy-
sis of the full M3 model that excluded SNP-to-gene distance as a predictor (model “M3B”). In
this M3B model, the effect estimates of the other predictors (MAF, eQTL, and chromatin state)
were essentially unchanged (data not shown), emphasizing the importance of functional anno-
tations as more direct indicators of relevance. Similarly, in comparing the ROC curves of the
two models, we found that the AUC for M3B was 0.652, which was very similar, but slightly
lower, than that of the complete model (M3, AUC = 0.654), suggesting that distance provided
only marginally more information once other functional annotations were considered. Inter-
estingly, the added value of including distance appeared to be in its influence on discriminatory
power at the uppermost part of the predicted probability distribution: the maximum predicted
probability observed fell from 10.0% in the full M3 model to 9.1% in the M3B model excluding
distance, suggesting that the value of distance as a predictor is in its ability to assist in prioritiz-
ing those variants with multiple functional annotations, up-weighting those that are more
proximal to genes.
Fourth, we noted the seemingly continuous influence of eQTL potential as a predictor of
disease association, even among variants with weak evidence for eQTL association. Though by
far the strongest predictors of disease association were for those SNPs with the most significant
evidence of eQTL association (i.e., the lower the eQTL FDR, the greater the odds for being a
GWAS hit), significant residual association was observed for eQTL variants with FDR = 5–10%
(OR = 1.6, P = 5.1 × 10−14) or 10–50% (OR = 1.2, P = 1.3 × 10−15), compared to those with
FDR> 50% (reference). Nonetheless, the sparseness of Table 2 emphasized that only SNPs
with FDR< 10% (and overlapping five specific chromatin states) were found in the highest
prediction bins of the full model.
Finally, we illustrated the components of the predicted probability results in the context of
interrogating a particular disease locus to prioritize non-coding variants for further study. Fig 7
shows a genomic region previously identified in a GWAS of system sclerosis (P = 2.3 × 10−12)
mapping near the interferon regulatory factor 8 (IRF8) gene [38]. Four polymorphisms in
strong LD in this region had previously been reported as an IRF8 eQTL in a meta-analysis of
four HapMap populations (including CEU) [39]. Of these, only one (rs11642873) emerged as a
significant candidate in our eQTL meta-analysis. Moreover, this variant resides within a pre-
dicted weak/poised enhancer region in LCLs, providing additional functional support. In our
predictive model, this SNP had the strongest regional evidence as a disease-associated variant
(probability = 6.3%), and indeed was the most strongly associated systemic sclerosis variant
reported in the region [38]. This preponderance of data supporting rs11642873 as a functional,
disease-associated variant would thus motivate experimental validation of this specific locus.
Discussion
Distinguishing the relatively small proportion of phenotypically relevant functional non-cod-
ing genetic variants from among millions of neutral variants segregating in human populations
remains a daunting, yet important, task. Many approaches have been proposed that rely on
specific characteristics of the sequence surrounding a variant, including its physical location
within known or predicted regulatory regions or transcription factor binding sequence motifs,
or the degree of sequence conservation of alleles within or across phyla [6]; yet no single
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distinguishing feature has emerged that can be confidently relied upon. The recent availability
of rich genomic sequence annotations of chromatin marks via projects such as ENCODE [4],
and the recognition of specific chromatin states that correspond to local transcriptional activity
represent an important further advance [12], together with multiple publications demonstrat-
ing significant enrichment for regulatory polymorphisms among GWAS-identified variants [2,
3, 9], provide incentive to consider the joint effects of these different sources of information.
Here, we demonstrate the value of combining multiple lines of information to improve
our predictive capabilities for identifying disease-associated genetic candidates. We leveraged
the power of eQTL meta-analysis in combination with other available genomic SNP annota-
tions to develop logistic multivariate models to predict disease relevance. Our complete M3
model that incorporated information on eQTL associations along with chromatin states
Fig 7. Evidence for an eQTL signal at the IRF8 locus associated with systemic sclerosis. Top panel:–log10 FDR for meta-analysis associations of
nearby SNPs with expression of the longer isoform of IRF8. Middle panel: Chromatin states (CS) in LCLs (GM12878) [12] and the target IRF8 transcript. The
two most strongly associated SNPs (including the systemic sclerosis GWAS [38] index SNP rs11642873) overlap a predicted weak enhancer region (yellow).
Nearby upstream is a predicted active promoter region (red) that is likely spurious given that it overlaps no gene, predicted or otherwise. Bottom panel:
boxplots showing probe expression residuals by genotype of index SNP rs11642873 in the four individual cohorts, where the “A” allele is A and the “B” allele
is C. None of the cohort-specific associations are individually significant at FDR < 5%, though the meta-analysis is significant at this level.
doi:10.1371/journal.pone.0140758.g007
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outperformed the others, enabling better discrimination and wider separation of probability
estimates between variants, particularly through the identification of a subset of variants most
strongly enriched for GWAS hits. Most notable, even when combined with other SNP annota-
tions that are correlated with it, eQTL association information enhanced the ability of our pre-
dictive model to prioritize variants. The observation that even moderate to modest evidence for
an eQTL (FDR = 5–50%) was strongly and significantly predictive suggested that although
hard significance threshold cutoffs do provide for greater confidence for those variants that are
given highest prioritization, the arbitrary setting of such cut-points may result in the loss of
valuable information when attempting to prioritize non-coding genetic variation. Considering
the known enrichments for eQTLs and for GWAS SNPs in chromatin-regulated regions (sum-
marized in [40]), it would not have been surprising if chromatin state information alone would
have been sufficiently predictive. While the dynamic range of the M2 model was slightly
reduced compared to M1 upon including chromatin state, the biological interpretability of its
predictions were qualitatively improved, being able to suggest mechanistic hypotheses beyond
what a simple distance measure can provide. The evolution of the prediction model also identi-
fied two specific classes of enhancer chromatin states as meriting closer attention in forming
those hypotheses. Overall, the extent to which the inclusion of eQTL information improved
model prediction, particularly for the subset of variants with the highest probabilities of being
disease-associated, was thus particularly striking, and further implicates regulatory potential as
an important determinant of the phenotypic potential of a variant.
Our work further highlights the ongoing need to more fully catalog the spectrum of regula-
tory genetic variation in human populations, and the potential benefit of applying meta-ana-
lytic approaches in this regard. The gains in eQTL detection achieved by our initial meta-
analysis clearly illustrate this benefit. In our study, of the 788 genes identified only by eQTL
meta-analysis, only 28 (3.6%) harbor at least one previously disease- or trait-associated SNP.
However, among these 788 eQTL genes, our predictive model identified no fewer than 567
SNPs with the highest predicted probability of being GWAS hits (predicted
probabilities> 6.3%), corresponding to 138 genes (24%). Examining the entire testing set, of
the 78,228 SNP-probe pairs with such high prediction probabilities, only a fraction (7,101 or
9.1%) are currently present in the NHGRI GWAS Catalog; the remainder may therefore repre-
sent plausible candidates simply not yet implicated by GWAS. These should be considered as
priorities for consideration in reinterpretation of available GWAS datasets. To help facilitate
such efforts, we have made the full set of prediction scores, together with the eQTL meta-analy-
sis results, available for download.
The predictive scores can also be used to prioritize variants for functional characterization,
including the prioritization of tightly linked variants within a disease-associated region that all
demonstrate similar evidence of disease association. In such scenarios, the ability to rank order
variants based on their functional characteristics and their likelihood of being disease-associ-
ated may help reduce the number of loci to be evaluated functionally to a manageable handful.
We have highlighted one such example at the IRF8 GWAS locus for systemic sclerosis, but a
more systematic examination of the data motivated by interests in particular diseases and/or
traits is needed. Thus, an important future application of this predictive model work is to apply
such prioritization metrics to published GWAS results, analogous to a method for using eQTL
evidence as weighted priors to improve statistical power when re-analyzing GWAS data [41].
While the work presented here illustrates a potentially useful approach for the enhanced
identification of disease-associated variants, the fact that our highest probability estimates peak
at 10.0% highlights the need for further improvements. To this end, we recognize some limita-
tions of the current model that if addressed may improve its predictive capabilities. Foremost
would be the extension to eQTLs and chromatin state data representative of the diverse set of
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tissues and cell types. Our current model includes eQTL data from whole blood, circulating
CD4+ lymphocytes, and LCLs–a rather narrow spectrum of related cell types. While potentially
sufficient for ranking variants related to immune or inflammatory disorders, consideration of
eQTL data from other tissues and cells (including, liver, adipose, and neurological tissue) may
help improve the ability of the model to predict susceptibility variants for diseases of those
organs [18]. The strong enrichment of our eQTL results for immune and metabolic traits, but
not for height- or cancer-related variants supports this possibility. Extensions of the meta-ana-
lytic eQTL approach to explicitly model cell-type specificity have been proposed to gain addi-
tional statistical power to detect eQTLs [16–18]. Our approach to eQTL enumeration may also
have some biases owing to the use of association yield optimization to choose latent factors for
adjustment in the association model. Finally, in review, we were made aware of a recent publi-
cation describing an analogous and comparable logistic regression model for predicting SNP
disease relevance [42], which illustrates how our differing choices in model construction
related to source annotations (e.g., blood eQTLs vs. blood+brain+liver eQTLs; summary chro-
matin states vs. individual genomic marks) and statistical methodologies (e.g., standard vs. reg-
ularized logistic regression; size and membership of testing and training sets) indeed tune the
prediction problem for all disease-associated variants and for specific sub-groups of them.
Another inherent limitation of our methodological approach to the question of predicting
the disease relevance of genetic variants was our reliance on the GWAS Catalog for the training
and testing of our models. Though fairly comprehensive in its inclusion of a very large propor-
tion of published associations detected by GWAS, the Catalog only summarizes associations
for those variants specifically discussed in published manuscripts. More accurate representa-
tions of the disease association propensity of a variant would come from consideration of
deeper sets of phenotypic association results, rather than limiting inclusion to the most
strongly associated variants and reliance on the reporting practices of individual research
groups. To do so would require access to the summary statistics for all variants across all stud-
ies. Though summary statistics are available for a subset of published GWAS, the GWAS Cata-
log includes a much larger sampling of disease phenotypes. Thus, our focus on the GWAS
Catalog as a reference represents a tradeoff between breadth (the diverse number of diseases
and traits represented in the GWAS Catalog) and depth (the complete set of summary statistics
for a smaller subset of GWAS). Furthermore, the GWAS Catalog is biased against lower-fre-
quency SNPs because GWAS are inherently underpowered to detect significant associations
for low-frequency variants. This skewing towards more common variants could certainly influ-
ence the predictive characteristics of our model. Despite these limitations, our results should
motivate additional efforts to characterize the regulatory and disease potential of genetic
variation.
In summary, we have demonstrated the utility of combining eQTL association data across
multiple populations and tissue types to increase power for eQTL detection and the additional
value in leveraging that information to prioritize disease-associated non-coding SNPs for fur-
ther functional characterization.
Supporting Information
S1 Fig. Quantile-quantile plot of meta-analysis eQTL associations shows substantial
enrichment of associations. For each of 7,672,940 SNP-probe pairs, position on the y-axis is
the observed χ2 test statistic and position on the x-axis is the expected χ2 test statistic based on
a permuted distribution. For clarity, the count of SNP-probe pairs within a given range bin of
observed χ2 test statistics are shown rather than plotting each individual point. For example,
the first count in the bottom left-hand corner is the count of pairs in the range 0 χ2< 1.3
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and the last count in the top right-hand corner is in the count in the range χ2 87.9. The hori-
zontal lines represent different thresholds of false discovery rates (0.1%, 0.5%, 1%, and 5%).
(TIF)
S2 Fig. Forest plot of component effects of two smaller GWAS predictive models based on
training set of SNPs. Odds ratios (black squares) for model features predicting the member-
ship of a SNP in the NHGRI GWAS Catalog are shown here with standard errors (gray lines).
The complete multivariate model is shown in Fig 4. There are three classes of SNP annotation
represented in each of the two models, each with multiple levels: distance from the transcript
boundaries of its target gene, its MAF, and its gene structural classification (“structure [M1]”,
top panel) or predicted chromatin state in GM12878 LCLs [12] (“chromstate [M2]”, bottom
panel). The base levels for each annotation are “0 kb (within gene)” [Distance from Gene],
“>10%” [MAF], and “none” [Structural Annotation] or “Heterochromatin (13)”
[ChromHMM].
(TIF)
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